Key result
Second-generation telemedicine with AI shows emerging benefits for chronic heart failure admissions and mortality.
Why the study?
To review literature and Internet sources on telemedicine projects in heart failure, focusing on remote monitoring in second-generation projects and trials, particularly in France.
Does telemedicine improve clinical outcomes in patients with chronic heart failure?
Does telemedicine improve clinical outcomes in patients with chronic heart failure?
Second-generation telemedicine projects incorporating new technologies and AI show promise in improving clinical outcomes for chronic heart failure patients.
May support integration of AI-connected telemonitoring in chronic HF; leaves open optimal implementation pending further RCTs.
BACKGROUND: This is a narrative review of both the literature and Internet pertaining to telemedicine projects within the field of heart failure, with special attention placed on remote monitoring of second-generation projects and trials, particularly in France. RESULTS: Since the beginning of the 2000's, several telemedicine projects and trials focused on chronic heart failure have been developed. The first telemedicine projects (e.g., TEN-HMS, BEAT-HF, Tele-HF, and TIM-HF) primarily investigated telemonitoring or for the older ones, telephone follow-up. Numerous second-generation telemedicine projects have emerged in Europe over the last ten years or are still under development for computer science heart failure, especially in Europe, such as SCAD, OSICAT, E-care, PRADO-INCADO, and TIM-HF2. The E-care telemonitoring project fits within the telemedicine 2.0 framework, based on connected objects, new information and communication technologies (ICT) and Web 2.0 technologies. E-care is the first telemedicine project including artificial intelligence (AI). TIM-HF2 is the first positive prospective randomized study with regards to EBM with positive significant clinical benefit, in terms of unplanned cardiovascular hospital admissions and all-cause deaths. The potential contribution of second-generation telemedicine projects in terms of mortality, morbidity, and number of hospitalizations avoided is currently under study. Their impact in terms of health economics is likewise being investigated, taking into account that the economic and social benefits brought up by telemedicine solutions were previously validated by the original telemedicine projects.
No takes yet. Share an insight, caveat, or question.
Andrès et al. (2018) conducted a review in Chronic Heart Failure. Telemedicine was evaluated. Second-generation telemedicine projects using connected objects and AI are emerging for chronic heart failure, with trials like TIM-HF2 showing clinical benefits in hospital admissions and mortality.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: